Peanut Allergy Treatment Archives - DelveInsight

Peanut Allergy Treatment

peanut-allergy-market-size-share-trends-prevalence-therapies-therapeutics-drugs
Peanut Allergy Market Outlook: The Market Size Growth Sees Major Thrusts

Peanut allergy (PA) is one of the most common food allergies that affect children in Western nations. It is diagnosed at early stages and often persists till adulthood in approximately 75%–80% of ...


Pharma News
First-ever Peanut allergy treatment; Dinutuximab misses primary endpoint; Insmed’s shares S...

The US FDA has given its recommendation to the Aimmune Therapeutics’ drug, Palforzia, the first-ever treatment for Peanut Allergy. Palforzia is an oral immunotherapy, set to address the unmet ...


Editor's Pick
22 Healthcare Trends & Innovations to Watch in 2022 and Beyond

With the advent of new-age healthcare industry trends that are evident as of now, there...

Assessment of Key Products that Got FDA Approval in Second Half (H2) of 2021

Although COVID-19 continued to dominate headlines in 2021, pharmaceutical companies did...

Analyzing the Key Trends Driving the Biosimilar Market Growth

The Biosimilars market is growing at a breakneck pace. The biosimilar market provides a...

CAR-T Cell Therapy aka Miraculous Technology: Mapping the Market, Approved Th...

Chimeric antigen receptor T-cell (CAR T) therapies are shown to have transformative pot...

Myelodysplastic Syndromes (MDS): Key Pharma Players Unveiling Updated Finding...

There has been limited progress in the approval of novel agents in MDS. It has been a l...

ASCO Conference 2021
ASCO Conference 2021

The American Society of Clinical Oncology is a platform that provides a global connection to researchers, pharma companies, and healthcare professions standing against cancer, finding a cure for it.